| pubmed-article:11468166 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0015576 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0680022 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0042974 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0376525 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0042971 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:11468166 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11468166 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11468166 | pubmed:dateCreated | 2001-7-24 | lld:pubmed |
| pubmed-article:11468166 | pubmed:abstractText | The 3' end of the VWF gene was screened in the affected members of 3 different families with type 2A (phenotype IID) von Willebrand disease (vWD). Exons 49 to 52 of the VWF gene were amplified and screened for mutations by chemical cleavage mismatch detection. Mismatched bands were detected in exon 52 of 2 patients and in exon 51 of a third patient. Using direct DNA sequencing, a heterozygous G8562A transition leading to a Cys2008Tyr substitution was found in all the patients in family 1, and a T8561A transversion leading to a Cys2008Ser substitution was found in both patients from family 2. In a patient from a third family, an 8-base deletion from nucleotide 8437 to 8444 was identified in exon 51. The 2 mutations in exon 52 were reproduced by in vitro site-directed mutagenesis of full-length von Willebrand factor (vWF) cDNA and transiently expressed in COS-7 cells. The corresponding recombinant VWFs for these 2 mutations exhibited the typical aberrant vWF:Ag multimer pattern seen in the plasma of the patients. These 3 mutations demonstrate the importance of other carboxy-terminal cysteines in addition to the reported Cys2010 residue, in the normal dimerization of vWF, and their essential role in the assembly of normal multimeric vWF. (Blood. 2001;98:674-680) | lld:pubmed |
| pubmed-article:11468166 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11468166 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11468166 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11468166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11468166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11468166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11468166 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11468166 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:11468166 | pubmed:issn | 0006-4971 | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:HillF GFG | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:EnayatM SMS | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:WilliamsM DMD | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:TohC HCH | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:PasiK JKJ | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:JenkinsP VPV | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:GuilliattA... | lld:pubmed |
| pubmed-article:11468166 | pubmed:author | pubmed-author:SurdharG KGK | lld:pubmed |
| pubmed-article:11468166 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11468166 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11468166 | pubmed:volume | 98 | lld:pubmed |
| pubmed-article:11468166 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11468166 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11468166 | pubmed:pagination | 674-80 | lld:pubmed |
| pubmed-article:11468166 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:meshHeading | pubmed-meshheading:11468166... | lld:pubmed |
| pubmed-article:11468166 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11468166 | pubmed:articleTitle | Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease. | lld:pubmed |
| pubmed-article:11468166 | pubmed:affiliation | Molecular Haemostasis Laboratory, Department of Haematology, The Birmingham Children's Hospital NHS Trust, Steelhouse Lane, Birmingham, B4 6NH, UK. said.enayat@bhamchildrens.wmids.nhs.uk | lld:pubmed |
| pubmed-article:11468166 | pubmed:publicationType | Journal Article | lld:pubmed |
